Xiaolan Ling
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- Organic Chemistry top 10%
- Asymmetric Synthesis and Catalysis
- Synthesis and biological activity
- Multicomponent Synthesis of Heterocycles
Papers in
-
- Crystal structures of chemical compounds 3
-
- Quality and Supply Management 1
- Co-authors
- Jianyong Chen (1 shared paper)Jack Wu (1 shared paper)Dajun Yang (1 shared paper)Ayad M Al-Katib (1 shared paper)Shaomeng Wang (1 shared paper)Amro Aboukameel (1 shared paper)Sanjeev Banerjee (1 shared paper)Ramzi M. Mohammad (1 shared paper)
- Journals
- Cancer Biology & Therapy (1 paper)Journal of Medicinal Chemistry (1 paper)Proceedings of the National Academy of Sciences (1 paper)Drug Discovery Today (1 paper)
- Partner nations
- United StatesIndiaChina
In The Last Decade
Xiaolan Ling
4 papers receiving 635 citations
Peers
Comparison fields: 5 of 46
- Oncology 290
- Organic Chemistry 147
- Computational Theory and Mathematics 46
- Molecular Biology 162
- Genetics 12
Countries citing papers authored by Xiaolan Ling
This map shows the geographic impact of Xiaolan Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Ling more than expected).
Fields of papers citing papers by Xiaolan Ling
This network shows the impact of papers produced by Xiaolan Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Ling. The network helps show where Xiaolan Ling may publish in the future.
Co-authors
The 15 scholars most cited alongside Xiaolan Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 595 | |
| 2 | 2008 | 35 | |
| 3 | 2021 | 25 | |
| 4 | 2013 | 1 | |
| 5 | 2021 | 0 | |
| 6 | 2021 | 0 | |
| 7 | 2021 | 0 |
About Xiaolan Ling
Xiaolan Ling is a scholar working on Inorganic Chemistry, Management Information Systems, Pathology and Forensic Medicine, Strategy and Management and Oncology, having authored 7 papers that have together received 656 indexed citations. Recurring topics across this work include Crystal structures of chemical compounds (3 papers), Management and Optimization Techniques (1 paper), Management Systems and Quality Improvement (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Cell death mechanisms and regulation (1 paper), Quality and Supply Management (1 paper), Cancer-related Molecular Pathways (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Oncology (290 citations), Organic Chemistry (147 citations), Computational Theory and Mathematics (46 citations), Molecular Biology (162 citations) and Genetics (12 citations). Xiaolan Ling has collaborated with scholars based in United States, India and China. Frequent co-authors include Jianyong Chen, Jack Wu, Dajun Yang, Ayad M Al-Katib, Shaomeng Wang, Amro Aboukameel, Sanjeev Banerjee, Ramzi M. Mohammad, Zaneta Nikolovska‐Coleska and Yuan Sun. Their work appears in journals such as Cancer Biology & Therapy, Journal of Medicinal Chemistry, Proceedings of the National Academy of Sciences and Drug Discovery Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.